Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1456-1458, 2004; 10.1373/clinchem.2003.030015
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernández-Real, J. M.
Right arrow Articles by Ricart, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernández-Real, J. M.
Right arrow Articles by Ricart, W.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2004;50:1456-1458.)
© 2004 American Association for Clinical Chemistry, Inc.


Technical Briefs

Circulating Soluble CD14 Monocyte Receptor Is Associated with Increased Alanine Aminotransferase

José Manuel Fernández-Real1,2,a, Abel López-Bermejo1, Montserrat Broch2, Joan Vendrell2, Cristobal Richart2 and Wifredo Ricart1,2

1 Section of Diabetes, Endocrinology and Nutrition, University Hospital of Girona "Dr Josep Trueta", Girona, Spain;2 Unit of Endocrinology and Nutrition, University Hospital of Tarragona "Joan XXIII", Unit of Advanced Studies, Tarragona, Spain

aaddress correspondence to this author at: Unitat de Diabetes, Endocrinologia i Nutrició, Hospital de Girona "Dr Josep Trueta", Carretera de França s/n, 17007 Girona, Spain; fax 34-972-94-02-70, e-mail uden.jmfernandezreal@htrueta.scs.es

The first 300 words of the full text of this article appear below.

Recent studies have suggested that abnormal hepatocellular function is associated with obesity, insulin resistance, and type 2 diabetes (1)(2)(3). Nonancoholic fatty liver disease (NAFLD) is the preferred term to describe a spectrum of liver damage, ranging from steatosis to steatohepatitis, liver fibrosis, and cirrhosis, that can be found in insulin-resistant (obese and type 2 diabetic) and hyperlipidemic patients (4). Insulin sensitivity and liver function exhibit a bidirectional relationship: a normally functioning liver determines, in part, the normal body response to insulin, whereas abnormal insulin sensitivity causes liver damage (5)(6). The insulin-resistant state is characterized by a failure to suppress hepatic glucose production and glycogenolysis (5), usually accompanied by fat accumulation in hepatocytes as a result of increased hepatic uptake and synthesis of triglycerides. The latter is known to impair liver function and, consequently, to worsen insulin resistance (5)(6).

Aminotransferases are considered indicators of hepatocellular health. Alanine aminotransferase (ALT) is found primarily in the liver, whereas aspartate aminotransferase (AST) and {gamma}-glutamyltranspeptidase ({gamma}GT) are also found in other tissues. NAFLD is characterized by mild-to-moderate increases in ALT and AST (7). Recent prospective studies have shown that increased ALT and {gamma}GT are predictors of the development of type 2 diabetes (1)(2).

CD14, a 55-kDa glycoprotein, is a multifunctional receptor constitutively expressed in considerable amounts on the surface of mature monocytes, macrophages, and neutrophils (8). CD14 has specificity for lipopolysaccharide (LPS) and other bacteria-wall-derived components (9). LPS signaling triggers a cascade that leads to cytokine production and shedding of the extracellular domain of CD14 (sCD14) (10)(11)(12)(13). The buffering of LPS is crucial not only during acute inflammatory . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.